ExpressGraft Enhance

N/A

Report date: 2025/03/20 15:54:29

Base Information

Drug NameExpressGraft Enhance
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCathelicidin antimicrobial peptide stimulants
TargetsCathelicidin antimicrobial peptide
Therapy Area/IndicationsWounds and InjuriesDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-Madison
China Registration ClassN/A

Develop Information

Active CompaniesStratatech Corp
Inactive CompaniesUniversity Of Wisconsin-Madison
Active IndicationsWounds and InjuriesDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A